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Several studies have demonstrated differences among strains of probiotic bacteria with regard to their
survival in acid environment. Probiotics must survive in gastric acids to reach the small intestine and
colonize the host for appropriate prevention and management of several gastrointestinal diseases. To
improve the survival rates of probiotic microorganisms during gastric transit, microencapsulation is
considered to be a promising process. A variety of polymers are commonly used for microencapsulation.
Thus, there is a widespread interest in the improvement of the physical and mechanical stability of the
polymers use in probiotics encapsulation. In addition, there is a developing trend toward the use of milk
proteins as encapsulation device. To fulfill many demands of a successful probiotics encapsulation,
different techniques have been applied to increase the resistance of these sensitive microorganisms
against gastric conditions. Therefore, the objective of this study is to review the effect of microencap-
sulation on survival of probiotics in an in vitro model simulating gastric transit.
Copyright © 2016 Institut Pertanian Bogor. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Probiotics are live microorganisms that when present in suffi-
cient amounts in the digestive tract may confer health benefits on
the host (Lourens-Hattingh and Viljoen 2001). To promote their
beneficial effects in the host, probiotics must survive transit
through the harsh acidic conditions of gastric environment and
being capable of reaching the large intestine in adequate amounts
to enable colonization and proliferation (Li et al. 2011). It has been
recommended that food containing probiotic bacteria should be in
the range of 108e109 colony forming unit (cfu)/g right before
ingestion to ensure that sufficient therapeutic minimum of
106e107 cfu/g could reach the colon (Nazzaro et al. 2009). Unfor-
tunately, most of the probiotics lack the ability to survive in high
quantity because of low pH (pH ¼ 2) in gastric juice and/or expo-
sure to oxygen that limited their effectiveness in most functional
foods. Microencapsulation is a process in which the probiotic cells
are incorporated into an encapsulating matrix or membrane that
can protect the cells from degradation by the damaging
factors in the environment and release at controlled rates
under particular conditions (Desai and Park 2005). The purpose ofnian Bogor.
r. Production and hosting by Elsmicroencapsulation of probiotics is to protect them from the low
pH, bile salts, and other constituent products that it encounters
during gastrointestinal transit (Muthukumarasamy et al. 2006). A
microcapsule comprises a semipermeable or nonpermeable,
spherical, thin, and strong membrane surrounding a solid and
liquid core with very small diameter varying between a few mi-
crons and 1 mm. Encapsulation materials are generally recognized
as safe ingredients that can be used in food applications (Ei-Salam
and Ei-shibiny 2012). Food-grade polymers, such as alginate, chi-
tosan, carboxymethyl cellulose, xanthan gum, starch, carrageenan,
gelatin, and pectin, are largely applied using different microen-
capsulation techniques (Sultana et al. 2000; Muthukumarasamy
et al. 2006; Anal and Singh 2007; Ding and Shah 2009;
Mokarram et al. 2009; Chavarri et al. 2010; Cook et al. 2011, 2013).
In addition, there is a developing trend toward the use of encap-
sulation in milk proteins such as casein (Oliveira et al. 2007;
Heidebach et al. 2009a,b) and whey protein (Doherty et al. 2012).
Alginate is a natural polymer that is applied successfully as a pH-
sensitive material for the microencapsulation of probiotic bacteria
(Allan-Wojtas et al. 2008). However, to fulfill many demands of a
successful probiotics encapsulation, different techniques have been
applied to increase the resistance of these sensitive microorgan-
isms against gastric conditions including incorporation of some
food-grade polymers into the matrix of alginate (Sultana et al.
2000; Muthukumarasamy et al. 2006; Anal and Singh 2007; Dingevier B.V. This is an open access article under the CC BY-NC-ND license (http://
A.B. Shori2and Shah 2009; Mokarram et al. 2009; Chavarri et al. 2010; Cook
et al. 2011, 2013). Therefore, a vast number of publications were
used to review the effect of microencapsulation on survival of
probiotics in an in vitro model simulating gastric transit.
2. Milk Proteins-Based Microencapsulation
Coatings and mixtures of suitable biopolymers such as alginate
and k-carrageenan are of nondairy origin. Therefore, they are un-
desirable to use in dairy products in several countries (Picot and
Lacroix 2004). In the case of calcium alginate (Ca-alginate), there
is no pronounced barrier effect given at very low pH because of the
low density of the forming gel network (Crittenden et al. 2006;
Mortazavian et al. 2008). Alginate microspheres with porous
structure permit the diffusion of acid in and out of microspheres.
Besides, the large size of the produced beads (diameters between 1
and 3 mm) may induce contrary effects on the sensorial quality of
the enriched product. Carrageenan is used as an encapsulation
carrier because of its gelation property. It is a natural poly-
saccharide including a crosslinking structure by D-galactose-4-
sulfate and 3,6-dehydrated-D-galactose. However, probiotic bacte-
ria, such as Bifidobacterium bifidum, Lactobacillus acidophilus, Bifi-
dobacterium lactis, and Bifidobacterium infantis, were encapsulated
in k-carrageenan microcapsules or alginate microcapsules with 2%
resistant starch for supplementation of cheddar cheese (Godward
and Kailasapathy 2003). The authors found that the viable cell
numbers of all probiotic strains were higher in free cells cheddar
cheese than encapsulated cells during storage. This indicated that
the physiological conditions in a hydrocolloid matrix such as k-
carrageenan or alginate are less appropriate for the probiotic cells.
Caseins, whey proteins, and milk fat globule membrane proteins
present in milk are recognized as safe materials with high nutri-
tional and good sensory properties. The milk proteins also have
properties such as binding small molecules, self-assembly, excel-
lent gelation, pH-responsive gel swelling behavior, and ability to
interact with other polymers for the formation of complexes
(Livney 2010). Thus, milk proteins, especially whey proteins, showa
potential in the encapsulation of lactic acid bacteria. For example,
encapsulated yield of Lactobacillus bulgaricus in skim milk-alginate
microspheres was about 100% (Pan et al. 2013). Similarly, Hebrard
et al. (2009) obtained 95% of encapsulation efficiency of probiotic
yeast (Saccharomyces boulardii)-loaded microspheres with whey
protein and alginate in a ratio of 62:38. This can be attributed to the
excellent interaction between milk proteins and alginate-based
microspheres in Ca2þ solution for the formation of complexes. In
addition, the protective effects of the rennet cheese dense protein
matrix toward probiotic bacteria at low pH 2e2.5 have been re-
ported (Boylston et al. 2004). Heidebach et al. (2009a) investigated
the probiotic cells microencapsulated in milk protein matrices by
means of an enzymatic-induced gelation with rennet. The authors
reported that the survival rate of B. lactis and Lactobacillus paracaseiTable 1. The effect of milk proteins-based microencapsulation on the protection and sur
Probiotic Type of encapsulating material Probiotic
B. lactis
L. paracasei
Milk protein matrices with rennet 2.8 log cfu
0.8 log cfu
L. paracasei
B. lactis
Sodium caseinate gelled with transglutaminase 2 log cfu/
0.6 log cfu
L. casei Sodium caseinate and gellan gum mixture
gelled by glucono-d-lactone
3 log cfu/
L. bulgaricus Alginate-milk 1010 log c
L. rhamnosus GG Micellar casein and denatured whey proteins ~1011 cfu
B. lactis ¼ Bifidobacterium lactis; cfu ¼ colony forming unit; L. bulgaricus ¼ Lactobacil
L. rhamnosus ¼ Lactobacillus rhamnosus; [ ¼ higher than free cells.
* No change from initial counts..encapsulated inmilk protein significantly improved comparedwith
free cells at pH 2.5. The viable cell counts of encapsulated B. lactis
and L. paracasei were higher by 2.8 and 0.8 log units cfu/g,
respectively, than free cells after 90 minutes of exposure to low pH
(2.5) at 37C (Table 1). It has been shown that L. paracasei is more
sensitive to acid than B. lactis, which means the survival rate of
probiotics in low pH is strain dependent. According to
Muthukumarasamy et al. (2006), each probiotic strain has different
response mechanisms to tolerate low pH, which cannot be fully
recovered by microencapsulation. However, both strains achieved
higher survival rate of cells because of the entrapment in a pro-
tective environment of the microcapsules (Heidebach et al. 2009a).
Another study used sodium caseinate gelled with transglutaminase
(TGase) enzyme for L. paracasei and B. lactis encapsulation
(Heidebach et al. 2009b). This study found that the free cells of
L. paracasei and B. lactis were reduced by more than 5 and 3.3 log
cfu/g, respectively, after 90 minutes in simulated gastric fluid (SGF)
at pH 2.5. However, when the cells encapsulated in sodium
caseinate gelled with TGase, the reductions were about 3.0 and
2.7 log cfu/g for L. paracasei and B. lactis, respectively (Table 1). The
improved survival of encapsulated cells could be explained by the
reaction of TGase to induce crosslinks built on a covalent network
resulting in water-insoluble and physically stable gels resistant
against disbanding at low pH. L. casei cells were effectively
entrapped into sodium caseinate and gellan gummixture gelled by
gradually decreasing pH using glucono-d-lactone (Nag et al. 2011).
The viability of encapsulated cells was reduced by only 3.1 log cfu/g,
whereas free cells showed 6.1 log cfu/g reductions after 120 mi-
nutes in SGF. Several factors may act together to cause high viability
of encapsulated L. casei cells such as the synergistic effect between
gellan gum and sodium caseinate to provide additional gel strength
and preadaptability of bacterial cells in low pH caseinate gels (Nag
et al. 2011).
L. bulgaricus is very sensitive to low pH, and the viability of free
L. bulgaricus is dramatically lost on exposure to acidic condition.
Encapsulation of L. bulgaricus in alginate-milk microspheres
showed significant (p < 0.05) improvement in the survival of
L. bulgaricus in SGF (Shi et al. 2013a). This encapsulationmaintained
full viability of L. bulgaricus after 120 and 30 minutes of incubation
in SGF with pH 2.5 and 2.0, respectively (Table 1). The buffering
capacity of milk in microspheres may be responsible for the
excellent pH tolerance of encapsulated L. bulgaricus. Moreover, Shi
et al. (2013a) demonstrated that high milk concentration may lead
to form denser hydrogel network that could decrease the diffusion
rate of acid into the microspheres. The viability of encapsulated
L. bulgaricus reduced to around 1 log cfu/g in alginate:milk ratio of
1:4, whereas the reduction was more than 8 log cfu/g in algina-
te:milk ratio of 1:1 after 120 minutes in SGF with pH 2.0.
Encapsulation of Lactobacillus rhamnosus GG in microparticles
consisting of micellar casein and denatured whey proteins showed
99% of bacterial survival and 97% of encapsulation rate (Burgainvival of probiotics during simulated gastric fluid (pH 2.5) at 37C
viability (log cfu/g) Time of incubation (min) References
/g[
/g[
90 Heidebach et al. (2009a)
g[
/g[
90 Heidebach et al. (2009b)
g[ 120 Nag et al. (2011)
fu/g* 120 Shi et al. (2013a)
/g* 120 Burgain et al. (2013)
lus bulgaricus; L. paracasei ¼ Lactobacillus paracasei; L. casei ¼ Lactobacillus casei;
Table 2. The effect of alginate-based microencapsulation on the protection and survival of probiotics during simulated gastric fluid (pH 2.0) at 37C
Probiotic Type of encapsulating material Survival rate (%) Time of incubation (min) References
L. acidophilus CGMCC1.2686 Alginate-CaCO3
Alginate-Ca-ethylenediaminetetraacetate
22
7.1
120 Cai et al. (2014)
L. rhamnosus GG ATCC 53103
B. animalis DN-173 010
Ca-alginate 43
72
180 Guimar~aes et al. (2013)
B. longum BIOMA 5920 Alginate and human-like collagen 51 120 Su et al. (2011)
B. adolescentis 15703T Gelatin microspheres with alginate ~30 120 Annan et al. (2008)
B. adolescentis ¼ Bifidobacterium adolescentis; B. animalis ¼ Bifidobacterium animalis; B. longum ¼ Bifidobacterium longum; L. acidophilus ¼ Lactobacillus acidophilus;
L. rhamnosus ¼ Lactobacillus rhamnosus.
Probiotics survival during gastric transit 3et al. 2013). The improvement of encapsulation efficiency of
L. rhamnosus GG referred to micellar casein and the interaction
between probiotic strain and whey proteins.
3. Alginate-Based Microencapsulation
Alginate is a natural polymer that is applied successfully as a pH-
sensitive material for the microencapsulation of probiotic bacteria
(Allan-Wojtas et al. 2008). Alginate is a polysaccharide extracted
from algae composed of various amounts and sequential distribu-
tion of b-D-mannuronic (M) and a-L-guluronic acids (G) (block
copolymer containing both MM, GG, and irregular sequences of M
and G units) that can affect functional properties of alginate as a
supporting material (Burgain et al. 2011). When sodium alginate
solution containing cell suspension is poured into a calcium solu-
tion, the bound ions interact with other GG blocks to form a com-
plex that leads to gel formation and the probable release of
entrapped cells in the intestinal tract (Prakash and Jones 2005).
Alginate microencapsulation strategies have been established for
the ability to protect probiotic viability in the gastrointestinal
digestion (Hansen et al. 2002). Cai et al. (2014) demonstrated that
the protection efficiency of alginate-CaCO3 microcapsule for
L. acidophilus CGMCC1.2686 was stronger than alginate-Ca-ethyl-
enediaminetetraacetate (EDTA). The encapsulated L. acidophilus in
alginate-CaCO3 showed survival rate of 22% compared with 7.1% in
alginate-Ca-EDTA after SGF for 2 hours (Table 2). High performance
and productivity of alginate-CaCO3 microcapsule for L. acidophilus
against acidic injury might be explained by the improvement in
mechanical properties and denser structure of the alginate-CaCO3
microcapsules. One possible reason for higher mechanical strength
for alginate-CaCO3 microcapsules than alginate-Ca-EDTA could be
the neutral pH of alginate capsules that was adjusted after gelation
and solidification by using phosphate buffer. However, the increase
in chelating ability of EDTAwith Ca ions at neutral pHmay decrease
the integrity of Ca-crosslinked alginate network leading to a
decreasedmechanical strength of alginate capsules (Cai et al. 2014).
Moreover, the antimicrobial effect of EDTAmay cause some damage
to L. acidophilus by decreasing the stability of bacterial cell mem-
brane through complexing divalent cations that acted as salt
bridges between membrane macromolecules (Chang et al. 2012).
Another study developed new probiotic beads similar to fish eggsTable 3. The effect of chitosan-based microencapsulation on the protection and survival
Probiotic Type of encapsulating material
Enterococcus faecium MC13 Alginate-chitosan
L. gasseri
B. bifidum
Alginate-chitosan
L. casei Alginate-chitosan
Alginate-chitosan-carboxymethyl chitosan
B. breve Alginate-chitosan and fluid-bed drying
B. breve Poly D,L-lactic-co-glycolic acid containing prebiotic
galactooligosaccharides incorporated into an alginate-
Saccharomyces boulardii Chitosan/dextran sulphate
B. bifidum ¼ Bifidobacterium bifidum; B. breve ¼ Bifidobacterium breve; L. casei ¼ Lactobacto use in oriental cuisine (Guimar~aes et al. 2013). L. rhamnosus GG
ATCC 53103 and Bifidobacterium animalis DN-173 010 were
encapsulated in beads produced by the extrusion encapsulation
technique with Ca-alginate. Both free probiotic strains failed to
survive at low pH 2.0 and 2.5 after 180 minutes in SGF, whereas
encapsulated cells of L. rhamnosus and B. animalis showed viability
of 3.4 and 5.7 log cfu/g, respectively, at pH 2.0 (Guimar~aes et al.
2013; Table 2). Su et al. (2011) developed microspheres based on
alginate and human-like collagen for improving the survival of
Bifidobacterium longum BIOMA 5920 in SGF. They found that none
of free B. longum survived after exposure to SGF for 2 hours.
However, encapsulated B. longum in 1.5% (w/v) alginate and 2% (w/
v) human-like collagen survived about 4.81 log cfu/mL of 9.47 cfu/
mL (four log cycles reduction) after 2 hours in SGF. This level of
survival was better than using alginate alone that showed about
five log cycles reduction (from 9.02 to 3.77 log cfu/mL) during
2 hours of exposure to SGF. Previous study found that coating of
gelatin microspheres with alginate provided significant protection
for Bifidobacterium adolescentis 15703T from the harsh acidic con-
ditions of SGF (Annan et al. 2008). Encapsulated B. adolescentis
showed two log units higher in survival rates compared with free
cells after incubation in SGF at pH 2.0 for 2 hours (Table 2).
4. Chitosan-Based Microencapsulation
Cationic polymers such as chitosan can form gels with poly-
phosphate or sodium alginate (nontoxic multivalent anionic
counterions) by ionic crosslinking (Lucinda-Silva et al. 2010). The
coating of alginate beads and its efficiency in protecting probiotics
has been widely studied over a period of years. Previous study has
found that coating alginate microcapsules with chitosan had sig-
nificant effect on the stability of the alginate beads and thus
increased the survival rate of the encapsulated probiotics
(Krasaekoopt et al. 2003). According to Chavarri et al. (2010),
coating alginate beads with chitosan develops chitosan with algi-
nate complex. This complex decreases the porosity of alginate
beads, reduces the leak of the encapsulated probiotic, and shows
stability at low pH. Kanmani et al. (2011) showed no released cells
of Enterococcus faecium MC13 encapsulated into alginate-chitosan
capsules in SGF for 144 hours (Table 3). Similarly, Chavarri et al.
(2010) reported that the alginate-chitosan capsules enhancedof probiotics during simulated gastric fluid (pH 2.0) at 37C
Probiotic viability Time of
incubation
References
Nil 144 hr Kanmani et al. (2011)
7 log cfu/mL 120 min Chavarri et al. (2010)
7.38 log cfu/g
7.91 log cfu/g
120 min Li et al. (2011)
6.6 log cfu/mL 60 min Cook et al. (2011)
chitosan matrix
>4 log cfu/mL 60 min Cook et al. (2014)
7.19 log cfu/100 mg 120 min Thomas et al. (2014)
illus casei; L. gasseri ¼ Lactobacillus gasseri.
Table 4. The effect of plant materials-based microencapsulation on the protection and survival of probiotics during simulated gastric fluid at 37C
Probiotic Type of encapsulating material pH of gastric fluid Survival rate (%) Time of incubation (min) References
B. adolescentis Pea protein isolate-alginate with fructo-oligosaccharides pH 2.0 88.9 120 Klemmer et al. (2011)
L. bulgaricus Carrageenan-LB gum-coated milk pH 2.5
pH 2.0
100
80
120 Shi et al. (2013b)
L. rhamnosus Chitosan-coated alginate capsules with LB pH 3.0 92 60 Cheow et al. (2014)
B. adolescentis ¼ Bifidobacterium adolescentis; L. bulgaricus ¼ Lactobacillus bulgaricus; LB ¼ locust bean; L. rhamnosus ¼ Lactobacillus rhamnosus.
A.B. Shori4(p < 0.05) the survival rate of Lactobacillus gasseri and B. bifidum
(107 cfu/mL) when compared with free cells (10 cfu/mL) in simu-
lated gastric conditions after 2 hours. Alginate-chitosan and algi-
nate-chitosan-carboxymethyl chitosan microcapsules of L. casei
were found to maintain high viable cell counts (7.38 and 7.91 log
cfu/g, respectively) after 2 hours in SGF (Li et al. 2011; Table 3). This
may indicate that chitosan-coated alginate is very effective in
protecting probiotics in highly acidic environment. In contrast,
encapsulation into Ca-alginate without chitosan failed to protect
probiotic cells such as L. plantarum, L. acidophilus, L. rhamnosus, and
bifidobacteria in SGF (Sultana et al. 2000; Truelstrup Hansen et al.
2002; Gbassi et al. 2009; Mokarram et al. 2009). The impeding of
Ca-alginate matrix without chitosan coating happens in phosphate
buffer solution by chelating action of phosphate ions in pH
exceeding 5.5 (Dainty et al. 1986). The encapsulation techniques
used are very important to guarantee long-term delivery of stable
cultures in terms of viability (Carvalho et al. 2003). It has been
found that free Bifidobacterium breve showed zero survival after
1 hour exposure to SGF (Cook et al. 2011). However, the survival rate
of encapsulated B. breve in alginate-chitosan and fluid-bed drying
reduced by only 1 log cfu/mL and thus guaranteed higher viable cell
counts of about 6.6 ± 0.5 log cfu/mL after 1 hour in SGF (Cook et al.
2011). A recent study was conducted to investigate the effect of
incorporated B. breve into a multiparticulate consisting of poly D,L-
lactic-co-glycolic acid microcapsules containing prebiotic
galactooligosaccharides incorporated into an alginate-chitosan
matrix (Cook et al. 2014). Results showed significant reduction
(5 log cfu/mL) in the viable cell counts of the chitosan-coated
multiparticulate system after exposure to gastric conditions at pH 2
for 1 hour. This technique gives low viability of B. breve in gastric
condition (>4 log cfu/mL) compared with alginate-chitosan and
fluid-bed drying technique mentioned earlier (Cook et al. 2011;
Table 3). However, chitosan-coated multiparticulate system
showed latter significant increase in the viability of cells in intes-
tine section to about 8.0 ± 0.3 log cfu/mL, which could be associated
with the release of prebiotics (galactooligosaccharides) that stim-
ulated the growth of cells.
Recently, Saccharomyces boulardiiwas encapsulated by layer-by-
layer technique with oppositely charged polyelectrolytes such as
chitosan and dextran sulfate to protect it from low pH in SGF
(Thomas et al. 2014). The cell counts of encapsulated S. boulardii
were reduced by only 0.5 log cfu/100 mg to reach 7.19 ± 2.0 log cfu/
100 mg, whereas unencapsulated cells showed about 1.3 log cfu/
100 mg reductions after 2 hours in SGF of pH 2 (Table 3). The
possible reason for high survival of encapsulated S. boulardii is the
strong electrostatic interaction between the chitosan and dextran
sulfate polymer layers that led to dense structure for protecting the
yeast cells.
5. Plant Materials-Based Microencapsulation
Encapsulation of probiotics using plant-based materials may
play a role in food applications. Klemmer et al. (2011) reported that
viability of B. adolescentis in pea protein isolate-alginate micro-
spheres with fructo-oligosaccharides was highly improved (108 cfu/
mL) compared with free cells (10 cfu/mL) after 2 hours ofincubation in SGF with pH 2.0 (Table 4). Shi et al. (2013b) have used
puremilk as an inner layer for encapsulated L. bulgaricus in addition
to carrageenan-locust bean (LB) gum that was used as an outer
layer for coating the milk microspheres. Carrageenan-LB gum-
coated milk microspheres with double layer structure were pro-
duced to enhance the number of viable probiotic bacterial cells.
However, the authors discovered relatively low encapsulation yield
(~60%), which is caused by the poor film formation ability of milk
protein. Furthermore, high Ca2þ concentration (16 g/100 mL) in the
solution used for formulating microbeads may cause damage to
probiotics viability (Shi et al. 2013b). However, encapsulated
L. bulgaricus in carrageenan-LB gum-coated milk improved pH
stability with full and 8 log cfu/g viability of L. bulgaricus preserved
after 2 hours of incubation in pH 2.5 and 2.0 SGF, respectively
(Table 4). The improvement in survival numbers of encapsulated
probiotics can probably be explained by the buffering capacity of
the proteins-based capsule-matrix, dense structure, and low
porosity on the surface of the microspheres.
Recently, the effect of adding LB gum to chitosan-coated alginate
capsules on L. rhamnosus release profiles in SGF was investigated
(Cheow et al. 2014). Chitosan-coated alginate-LB capsules of
L. rhamnosus provided higher cells protection (92%) compared with
chitosan-coated alginate-xanthan and chitosan-coated alginate
(47% and 9%, respectively) after 1 hour in SGFwith pH 3. In addition,
chitosan-coated alginate-LB capsules released the smallest amount
of cells (4.0 log cfu/mg) compared with chitosan-coated alginate
capsules and chitosan-coated alginate-xanthan capsules (4.4 and
4.9 log cfu/mg) after 1 hour incubation in the SGF (Cheow et al.
2014). The authors suggested that a strong interaction between
chitosan and alginate-LB leads to more extensive chitosan coating
on the alginate-LB capsules, and high swelling capacity caused
dense structure that can withstand the low pH environments and
delay the onset of bulk capsule dissolution.
6. Conclusions and Perspectives
Several factors can effect the protection and survival of encap-
sulated probiotics during gastric transit such as acid resistance
properties of probiotic strains, encapsulating materials and their
concentrations, encapsulation methods, and types of polymers
incorporation in the matrix. Encapsulation of probiotics in
biocompatible multilayers using layer-by-layer technique is very
effective to improve the protection and viability of the probiotics in
gastric tract. Furthermore, chitosan-coated alginate microencap-
sulation significantly enhanced the stability of alginate in lowacidic
environments. Incorporation of milk, whey protein, and micellar
casein with alginate had significant effect to increase viability of
probiotics during gastric transit because of their pronounced
buffering capacity. In addition, the use of enzymes such as rennet
and TGase as gelling agents during probiotics encapsulation in
dairy-based matrices provides many promising opportunities for
enhancing probiotics protection in harsh acidic conditions of the
stomach. Since then, a number of studies regarding the relationship
between plant materials and probiotics have been successfully
established to increase the viability of probiotics. LB gum could be a
good choice as plant-based material for encapsulation
Probiotics survival during gastric transit 5development to provide sufficient protection against gastric acid.
However, few data are available to describe the effects of phenolic
compounds as a natural antimicrobial and adequate growth me-
dium into encapsulated probiotics. Food additives with prebiotic
properties have enhanced and stimulated the growth of cells in
encapsulated probiotics during gastric digestion. The mechanical
stability of capsules with probiotics could increase when applied
into a food matrix, considering that the presence of micronutrients
(glucose) may enhance the survival of probiotics during the gastric
digestion. In addition, this mechanism could be applied to improve
the shelf life of probiotics dairy products with low pH such as
yogurt.
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